US Stock MarketDetailed Quotes

10x Genomics (TXG)

Watchlist
  • 26.080
  • +0.840+3.33%
Close Apr 17 16:00 ET
  • 26.000
  • -0.080-0.31%
Post 20:01 ET
3.33BMarket Cap-74.51P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

10x Genomics (TXG) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
5.25%642.82M
0.61%166.03M
-1.75%149M
12.93%172.91M
9.84%154.88M
-1.28%610.79M
-10.30%165.02M
-1.30%151.65M
4.28%153.1M
5.01%141.01M
Operating revenue
5.25%642.82M
0.61%166.03M
-1.75%149M
12.93%172.91M
9.84%154.88M
-1.28%610.79M
-10.30%165.02M
-1.30%151.65M
4.28%153.1M
5.01%141.01M
Cost of revenue
1.34%198.94M
-2.00%52.99M
7.59%48.7M
-2.17%47.82M
2.80%49.44M
-6.26%196.3M
-20.72%54.07M
-22.12%45.26M
3.55%48.88M
33.98%48.09M
Gross profit
7.09%443.88M
1.88%113.05M
-5.72%100.31M
20.02%125.08M
13.49%105.45M
1.26%414.48M
-4.17%110.96M
11.37%106.39M
4.63%104.22M
-5.57%92.91M
Operating expense
-8.91%554.77M
-17.54%132.59M
-10.37%132.55M
-7.06%135.66M
-0.28%153.97M
-0.75%609.04M
6.21%160.79M
-0.70%147.88M
-10.44%145.96M
2.68%154.41M
Selling and administrative expenses
-8.19%316.13M
-18.34%76.62M
-7.77%75.36M
-10.36%74.43M
4.61%89.73M
0.30%344.34M
8.94%93.83M
-0.86%81.7M
-9.26%83.04M
2.99%85.77M
Research and development costs
-9.85%238.63M
-16.42%55.97M
-13.57%57.19M
-2.69%61.22M
-6.40%64.25M
-2.08%264.7M
2.61%66.97M
-0.50%66.17M
-11.95%62.92M
2.30%68.64M
Operating profit
43.01%-110.89M
60.79%-19.54M
22.28%-32.24M
74.67%-10.57M
21.09%-48.53M
4.79%-194.56M
-39.96%-49.84M
22.30%-41.49M
34.13%-41.74M
-18.29%-61.5M
Net non-operating interest income expense
5.93%20.05M
52.88%6.89M
4.69%5.2M
-9.46%4.27M
-22.15%3.69M
12.31%18.93M
-2.17%4.51M
15.59%4.97M
15.12%4.71M
22.99%4.74M
Non-operating interest income
5.91%20.05M
52.88%6.89M
4.65%5.2M
-9.42%4.27M
-22.17%3.69M
12.11%18.93M
-2.34%4.51M
15.60%4.97M
15.00%4.72M
22.41%4.74M
Non-operating interest expense
--0
----
----
200.00%3K
--0
-87.88%4K
--0
100.00%2K
-80.00%1K
-94.74%1K
Other net income (expense)
2,563.96%50.93M
16.56%-2.54M
-156.06%-1.17M
77,426.79%43.3M
1,190.00%11.34M
96.63%-2.07M
80.45%-3.05M
104.87%2.08M
96.28%-56K
31.40%-1.04M
Special income (charges)
--49.9M
--0
--0
--40.7M
--9.2M
--0
--0
--0
--0
--0
-Less:Other special charges
---49.9M
--0
----
---40.7M
---9.2M
----
----
----
----
----
Other non- operating income (expenses)
149.83%1.03M
16.56%-2.54M
-156.06%-1.17M
4,748.21%2.6M
305.38%2.14M
-622.73%-2.07M
-176.57%-3.05M
266.51%2.08M
96.28%-56K
31.40%-1.04M
Income before tax
77.54%-39.91M
68.60%-15.19M
18.10%-28.21M
199.78%37M
42.03%-33.51M
28.57%-177.7M
-3.82%-48.38M
62.46%-34.44M
38.98%-37.08M
-16.41%-57.8M
Income tax
-26.18%3.64M
63.43%1.06M
-155.74%-733K
200.61%2.46M
-60.30%852K
-22.24%4.93M
-72.47%648K
5.88%1.32M
-50.33%818K
96.34%2.15M
Net income
76.16%-43.54M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
28.41%-182.63M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.9M
-18.13%-59.95M
Net income continuous Operations
76.16%-43.54M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
28.41%-182.63M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.9M
-18.13%-59.95M
Minority interest income
Net income attributable to the parent company
76.16%-43.54M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
28.41%-182.63M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.9M
-18.13%-59.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
76.16%-43.54M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
28.41%-182.63M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.9M
-18.13%-59.95M
Basic earnings per share
76.97%-0.35
67.50%-0.13
26.67%-0.22
187.50%0.28
44.00%-0.28
30.28%-1.52
2.44%-0.4
62.03%-0.3
39.62%-0.32
-13.64%-0.5
Diluted earnings per share
76.97%-0.35
67.50%-0.13
26.67%-0.22
187.50%0.28
44.00%-0.28
30.28%-1.52
2.44%-0.4
62.03%-0.3
39.62%-0.32
-13.64%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 5.25%642.82M0.61%166.03M-1.75%149M12.93%172.91M9.84%154.88M-1.28%610.79M-10.30%165.02M-1.30%151.65M4.28%153.1M5.01%141.01M
Operating revenue 5.25%642.82M0.61%166.03M-1.75%149M12.93%172.91M9.84%154.88M-1.28%610.79M-10.30%165.02M-1.30%151.65M4.28%153.1M5.01%141.01M
Cost of revenue 1.34%198.94M-2.00%52.99M7.59%48.7M-2.17%47.82M2.80%49.44M-6.26%196.3M-20.72%54.07M-22.12%45.26M3.55%48.88M33.98%48.09M
Gross profit 7.09%443.88M1.88%113.05M-5.72%100.31M20.02%125.08M13.49%105.45M1.26%414.48M-4.17%110.96M11.37%106.39M4.63%104.22M-5.57%92.91M
Operating expense -8.91%554.77M-17.54%132.59M-10.37%132.55M-7.06%135.66M-0.28%153.97M-0.75%609.04M6.21%160.79M-0.70%147.88M-10.44%145.96M2.68%154.41M
Selling and administrative expenses -8.19%316.13M-18.34%76.62M-7.77%75.36M-10.36%74.43M4.61%89.73M0.30%344.34M8.94%93.83M-0.86%81.7M-9.26%83.04M2.99%85.77M
Research and development costs -9.85%238.63M-16.42%55.97M-13.57%57.19M-2.69%61.22M-6.40%64.25M-2.08%264.7M2.61%66.97M-0.50%66.17M-11.95%62.92M2.30%68.64M
Operating profit 43.01%-110.89M60.79%-19.54M22.28%-32.24M74.67%-10.57M21.09%-48.53M4.79%-194.56M-39.96%-49.84M22.30%-41.49M34.13%-41.74M-18.29%-61.5M
Net non-operating interest income expense 5.93%20.05M52.88%6.89M4.69%5.2M-9.46%4.27M-22.15%3.69M12.31%18.93M-2.17%4.51M15.59%4.97M15.12%4.71M22.99%4.74M
Non-operating interest income 5.91%20.05M52.88%6.89M4.65%5.2M-9.42%4.27M-22.17%3.69M12.11%18.93M-2.34%4.51M15.60%4.97M15.00%4.72M22.41%4.74M
Non-operating interest expense --0--------200.00%3K--0-87.88%4K--0100.00%2K-80.00%1K-94.74%1K
Other net income (expense) 2,563.96%50.93M16.56%-2.54M-156.06%-1.17M77,426.79%43.3M1,190.00%11.34M96.63%-2.07M80.45%-3.05M104.87%2.08M96.28%-56K31.40%-1.04M
Special income (charges) --49.9M--0--0--40.7M--9.2M--0--0--0--0--0
-Less:Other special charges ---49.9M--0-------40.7M---9.2M--------------------
Other non- operating income (expenses) 149.83%1.03M16.56%-2.54M-156.06%-1.17M4,748.21%2.6M305.38%2.14M-622.73%-2.07M-176.57%-3.05M266.51%2.08M96.28%-56K31.40%-1.04M
Income before tax 77.54%-39.91M68.60%-15.19M18.10%-28.21M199.78%37M42.03%-33.51M28.57%-177.7M-3.82%-48.38M62.46%-34.44M38.98%-37.08M-16.41%-57.8M
Income tax -26.18%3.64M63.43%1.06M-155.74%-733K200.61%2.46M-60.30%852K-22.24%4.93M-72.47%648K5.88%1.32M-50.33%818K96.34%2.15M
Net income 76.16%-43.54M66.85%-16.25M23.16%-27.47M191.14%34.54M42.69%-34.36M28.41%-182.63M-0.16%-49.03M61.55%-35.75M39.28%-37.9M-18.13%-59.95M
Net income continuous Operations 76.16%-43.54M66.85%-16.25M23.16%-27.47M191.14%34.54M42.69%-34.36M28.41%-182.63M-0.16%-49.03M61.55%-35.75M39.28%-37.9M-18.13%-59.95M
Minority interest income
Net income attributable to the parent company 76.16%-43.54M66.85%-16.25M23.16%-27.47M191.14%34.54M42.69%-34.36M28.41%-182.63M-0.16%-49.03M61.55%-35.75M39.28%-37.9M-18.13%-59.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 76.16%-43.54M66.85%-16.25M23.16%-27.47M191.14%34.54M42.69%-34.36M28.41%-182.63M-0.16%-49.03M61.55%-35.75M39.28%-37.9M-18.13%-59.95M
Basic earnings per share 76.97%-0.3567.50%-0.1326.67%-0.22187.50%0.2844.00%-0.2830.28%-1.522.44%-0.462.03%-0.339.62%-0.32-13.64%-0.5
Diluted earnings per share 76.97%-0.3567.50%-0.1326.67%-0.22187.50%0.2844.00%-0.2830.28%-1.522.44%-0.462.03%-0.339.62%-0.32-13.64%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -